reviewDrugsJan 16, 2023Closed access

Treating Head and Neck Cancer in the Age of Immunotherapy: A 2023 Update

ABAarti BhatiaBBBarbara Burtness

Yale Cancer Center

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

206
total citations
FWCI
61.64
Percentile
100%
References
327
Citations per year

Authors

2

Topics & keywords

Topics
Keywords
  • Medicine
  • Pembrolizumab
  • Cetuximab
  • Oncology
  • Head and neck squamous-cell carcinoma
  • Internal medicine
  • Nivolumab
  • Immunotherapy
No related works found for this paper.